Cited by

• Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study).

  Olson JE, Kirsch EJ, Edwards V DK, Kirt CR, Kneedler B, Laffin JJ, Weaver AL, St Sauver JL, Yost KJ, Finney Rutten LJ. Olson JE, et al. BMJ Open Gastroenterol. 2020 Feb 19;7(1):e000353. doi: 10.1136/bmjgast-2019-000353. eCollection 2020. BMJ Open Gastroenterol. 2020. PMID: 32128228 Free PMC article.
• A survey on colonoscopy shows poor understanding of its protective value and widespread misconceptions across Europe.

  Amlani B, Radaelli F, Bhandari P. Amlani B, et al. PLoS One. 2020 May 21;15(5):e0233490. doi: 10.1371/journal.pone.0233490. eCollection 2020. PLoS One. 2020. PMID: 32437402 Free PMC article.
• The impact of patient-reported factors of endoscopic screening experience on attendance at future examinations and distal colorectal cancer incidence.

  Power S, Wooldrage K, Thomas-Gibson S, Cross AJ. Power S, et al. BMC Cancer. 2025 Mar 6;25(1):409. doi: 10.1186/s12885-025-13771-3. BMC Cancer. 2025. PMID: 40050788 Free PMC article.
• Clinical Factors Associated with Adherence to the Follow-Up Examination after Positive Fecal Occult Blood Test in National Colorectal Cancer Screening.

  Kim BC, Kang M, Park E, Shim JI, Kang S, Lee J, Tchoe HJ, Kong KA, Kim DH, Kim YJ, Choi KS, Moon CM. Kim BC, et al. J Clin Med. 2020 Jan 18;9(1):260. doi: 10.3390/jcm9010260. J Clin Med. 2020. PMID: 31963658 Free PMC article.
• Patients Prioritize a Low-volume Bowel Preparation in Colitis-associated Colorectal Cancer Surveillance: A Discrete Choice Experiment.

  Wijnands AM, Te Groen M, Peters Y, Kaptein AA, Oldenburg B, Hoentjen F, Lutgens MWMD. Wijnands AM, et al. Inflamm Bowel Dis. 2022 Jul 1;28(7):1053-1060. doi: 10.1093/ibd/izab221. Inflamm Bowel Dis. 2022. PMID: 34487155 Free PMC article.